The Claim
In patients with progressive supranuclear palsy and corticobasal syndrome, the combined effect of glycemic variability and medial temporal lobe atrophy accounts for a greater proportion of cognitive decline than either glycemic variability or medial temporal lobe atrophy alone.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In patients with progressive supranuclear palsy and corticobasal syndrome, the combination of fluctuating blood sugar levels and shrinkage in the medial temporal lobe explains more of the decline in thinking abilities than either factor by itself.
See the scientific wording
In patients with progressive supranuclear palsy and corticobasal syndrome, glycemic variability and medial temporal lobe atrophy together explain a greater proportion of cognitive decline than either factor alone, suggesting a potential interaction between metabolic and neurodegenerative pathways.
Big swings in blood sugar damage blood vessels in the memory part of the brain, causing brain cells to die and shrink. At the same time, the brain gets less insulin, which normally protects brain cells and keeps communication between them working properly. When both problems happen together, thinking skills get worse faster than if either problem happened alone.
What the research says
1 studyIn people with these rare brain diseases, bigger swings in blood sugar and more shrinkage in the memory part of the brain together explain more of their thinking problems than either one alone. The study found that both factors combined hurt thinking more than just one by itself.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.